|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization (accretion) of premium (discount) on marketable securities | |||||
| Stock-based compensation | |||||
| Non-cash operating lease expense | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other noncurrent assets | |||||
| Accounts payable | |||||
| Accrued and other current liabilities | |||||
| Operating lease liabilities | |||||
| Other noncurrent liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Other | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of equity, net of issuance costs | |||||
| Follow On Offering | |||||
| At The Market Sales | |||||
| Total proceeds from issuance of equity, net of issuance costs | |||||
| Proceeds from exercise of stock options and employee stock purchase plan | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from exercises of pre-funded warrants | |||||
| Payment of accrued offering costs | |||||
| Follow On Offering | |||||
| At The Market Sales | |||||
| Total payment of accrued offering costs | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Components of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other noncurrent assets | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash paid for leases included in operating cash outflows | |||||
| Lease liability obtained in exchange for right-of-use asset | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Property and equipment included in accounts payable and accrued and other current liabilities | |||||
| Offering cost included in accounts payable and accrued expenses and other current liabilities | |||||
| Issuance of warrant in connection with Loan Agreement | |||||
Loading...